PRENTISS SMITH & CO INC NBIX Holdings History
PRENTISS SMITH & CO INC's Neurocrine Biosciences Inc Holding Summary
As of 2025-03-31, PRENTISS SMITH & CO INC held - shares of Neurocrine Biosciences Inc(NBIX), totaling N/A. This investment constitutes 0% of their stock portfolio, and PRENTISS SMITH & CO INC now holds 0% of the outstanding Neurocrine Biosciences Inc(NBIX) stock.
The initial trade took place in 2024Q4. And since then PRENTISS SMITH & CO INC has made 1 purchases of NBIX, at an average price of $123.84, for a total of 4,763.00 shares. In addition, there have been 1 sales at an average price of $126.68 for 4,763.00 shares. Based on historical transaction data and NBIX's current price of $134.11, PRENTISS SMITH & CO INC's estimated gain on his NBIX holdings is $13,526.92, reflecting a 2.29% gain to date.
PRENTISS SMITH & CO INC NBIX ($134.11) Holding Chart
PRENTISS SMITH & CO INC NBIX ($134.11) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price $-/Share | ||
Shares Sold | 0 | Average Price $-/Share | ||
Current Price $0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1